Neurology in Georgia

MagVenture is a privately owned Danish manufacturer of Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. The company has pioneered non-invasive TMS technology for over 30 years, serving clinicians, researchers, and diagnosticians globally. Products are designed, developed, produced, and quality-tested in Denmark and distributed through subsidiaries in the USA, Brazil, UK, China, and Germany, with presence in more than 70 countries. MagVenture TMS systems are FDA-cleared for treatment of Major Depressive Disorder (MDD) in adults and adolescents (15–21 years), Obsessive-Compulsive Disorder (OCD), anxiety-comorbid depression, and pain therapy. Systems also support diagnostic applications for stimulation of central and peripheral nervous systems, electrophysiological assessment via motor evoked potentials (MEP), and research in neuroscience, neurophysiology, neuroplasticity, and cognitive neuroscience. The company offers multiple therapy packages (R20, R30 standard and accelerated variants) with optional neuronavigation systems (Localite-Value and Localite-Premium), cooling systems, and specialized coils including the new T65 generation. Clinical support includes training, clinical protocols for standard and accelerated rTMS, and ongoing technical service.

Matrix Surgical USA designs, manufactures, and distributes OMNIPORE® porous high-density polyethylene implants for craniofacial reconstructive and aesthetic surgery. The company specializes in both standard surgical implants and customized patient-specific implants using advanced computer imaging and 3D modeling technologies. Product lines include facial augmentation implants (chin, malar, rim, midface, mandibular), neurosurgical implants for cranial and skull-based reconstruction, reconstructive shapes for traumatic defects and microtic ear reconstruction, orbital trauma correction implants (sheets, wedges, blocks), and spheres for enucleation and evisceration procedures. OMNIPORE implants have received FDA 510(k) clearance, CE marking in Europe, and regulatory approvals from ANVISA (Brazil), KFDA (South Korea), TFDA (Taiwan), TGA (Australia), and other stringent regulatory authorities. Manufacturing is performed in the USA to meet quality and reliability standards. The company serves plastic surgeons, otolaryngologists, neurosurgeons, and oral maxillofacial surgeons globally. Matrix Surgical USA operates with a subsidiary presence in Brazil as of 2024, expanding its international distribution and market reach in Latin America.

Mespere LifeSciences Inc. is a medical device innovator specializing in non-invasive, integrated hemodynamic monitoring solutions for cardiac and cerebral applications. The company develops advanced technologies for continuous, noninvasive monitoring of cardiac and neurological parameters, enabling real-time assessment of patient perfusion and hemodynamic status. Their product portfolio includes the Perfusion M system, designed to provide clinicians with integrated cardiac and cerebral monitoring capabilities without invasive procedures. Mespere's solutions are positioned for use in acute care, critical care, and perioperative settings where hemodynamic monitoring is essential for patient management and clinical decision-making. The company focuses on technology innovation in the patient monitoring segment, with emphasis on noninvasive methodologies that reduce procedural risk and improve patient comfort while maintaining clinical accuracy. Regulatory status and specific product certifications were not evident in the available content.

Sutter Medical Technologies USA is a subsidiary of Sutter Medizintechnik GmbH (Germany), a family-owned manufacturer of precision electrosurgical devices founded in 1970. The US operation, based in Alpharetta, Georgia, distributes advanced surgical instruments and radiofrequency generators for ENT, neurosurgery, and dermatological surgery specialties. Core product lines include the CURIS® 4 MHz radiofrequency generator (impedance-controlled electrosurgery for cutting and coagulation), Calvian endo-pen® bipolar forceps (endonasal and transnasal endoscopic surgery), and SuperGliss® non-stick bipolar forceps for microsurgery. The company is the exclusive US distributor of Clearmind Biomedical's Neuroblade System (FDA-cleared multifunctional neuroendoscope for minimally invasive neurosurgery) and the LARS Retractor 2.0 by Fentex Medical (modular laryngeal retractor for transoral robotic surgery and ENT procedures). Additional products include the CURIS® flow irrigation pump. Sutter emphasizes precision, quality, and non-stick technology to reduce char buildup and improve surgical field clarity. The parent company operates ~200 employees across 96,875 sq ft of manufacturing facilities in Germany with certifications supporting distribution in North America and Asia. Products are marketed toward hospital ORs, ASCs, and specialty surgical teams performing precision procedures in cranial base, laryngeal, and endoscopic surgeries.

Fehling Surgical Instruments, Inc. is a manufacturer of specialized surgical instruments focused on cardiac, thoracic, vascular, and neurological surgery. The company designs and produces precision surgical instruments including retractors, rongeurs, and innovative devices for minimally invasive cardiac procedures. Their product portfolio includes the Atrial Blade, a self-contained retractor for minimally invasive mitral valve repair offering precise manipulation of height, rotation, and angle for optimal surgical access. The company also manufactures Kerrisons and pituitary rongeurs, which have received FDA 510(k) certification. Fehling Surgical develops simulation systems and training platforms for surgical education, with their mitral valve retractor simulator specifically recommended by cardiac surgeons for simulation-based training in minimally invasive mitral valve surgery (MIMVS). The company serves cardiac surgeons, thoracic surgeons, neurosurgeons, and vascular surgeons globally, participating in major professional conferences including AATS, ISMICS, STS, CNS, and EACTS. They maintain regulatory compliance with FDA 510(k) clearances and operate with quality standards appropriate for surgical instrument manufacturing. Fehling Surgical maintains an international presence with operations in both the United States and Germany.

Brain Ultimate, Inc. is a neuromodulation and neurophysiology company offering FDA-cleared transcranial magnetic stimulation (TMS) systems for depression and obsessive-compulsive disorder, as well as comprehensive neurophysiology diagnostic equipment through its EB Neuro division. The company's flagship Brain Ultimate TMS system is distinguished by proprietary deionized water cooling technology enabling true 24/7 continuous operation without overheating—a capability unique in the TMS market. The system offers four FDA-cleared treatment protocols: Standard MDD (19 min), iTBS accelerated protocol (3 min), Enhanced MDD (37 min), and OCD-targeted protocol (18 min). The device features intelligent system monitoring with automatic safety cutoffs at 42°C, precision targeting via 10-20 system caps and neuronavigation compatibility, and cloud-connected treatment management through the HIPAA-compliant Brain Ultimate Cloud platform ($150/month base). Operating in 50+ clinics nationwide, the company reports 208 peer-reviewed studies and 5,000+ study participants supporting its technology. Through EB Neuro—a sister company with 70+ years of European neurophysiology expertise—Brain Ultimate also supplies FDA-cleared EEG, EMG/EP, and critical care monitoring platforms across multiple configurations (BE Plus PRO, BE Plus LTM, Neurotravel Light, ICU EEG-SEP, NeMus Series, BE Micro), serving 50+ countries. Manufacturing is conducted in partnership with Shenzhen Yingchi Technology Co., Ltd. The company operates with no per-pulse or per-use fees and provides 24/7 technical support.

Alpha Omega Engineering Ltd. is a specialized neuroscience and neurosurgery technology company developing advanced systems for neurophysiology research, deep brain stimulation (DBS) procedures, and clinical applications. The company manufactures microelectrode recording (MER) systems, brain mapping software, and DBS navigation tools used in human, primate, and rodent research settings, as well as in clinical neurosurgery and functional neurology. Their product portfolio includes portable and stationary MER systems with target localization capabilities, motorized commutators for free-moving animal studies, and neurological patient management platforms. Alpha Omega serves research institutions, neurosurgical centers, and clinical research organizations globally, supporting thousands of DBS procedures annually. The company emphasizes engineering precision, data reliability, and repeatability in neurophysiological signal acquisition. Their clinical research solutions integrate sophisticated hardware and software for brain mapping in both awake and asleep DBS procedures for the treatment of movement disorders and psychiatric conditions. Alpha Omega provides comprehensive customer support, technical engineering assistance, and training to optimize system implementation and clinical outcomes.

Elekta AB is a global leader in precision cancer care, specializing in radiotherapy and radiosurgery systems for oncology treatment. With over 50 years of experience, the company develops advanced solutions for adaptive radiotherapy—a precision treatment approach that adjusts to patient anatomy changes during therapy. Elekta's product portfolio includes linear accelerators for external beam radiotherapy, the Leksell Gamma Knife for stereotactic radiosurgery, and integrated imaging and software systems for treatment planning and guidance. The company serves cancer centers and hospitals worldwide, addressing multiple tumor types including head and neck, breast, prostate, brain, gynecological, kidney, and pancreatic cancers. Elekta's adaptive radiotherapy platform combines daily imaging, AI-assisted planning, and real-time treatment adjustment to optimize dose delivery while protecting healthy tissue. The company supports clinical workflows with comprehensive software solutions for treatment planning, image guidance, and outcome tracking. Elekta maintains a strong commitment to clinical evidence generation and supports leading oncology institutions globally. As a publicly traded company headquartered in Sweden, Elekta operates a global infrastructure including manufacturing, service centers, and training facilities. The organization emphasizes precision medicine innovation and advancing radiotherapy as a standard of care across diverse patient populations and healthcare settings.

Alliance Spine and Pain Centers is a leading interventional pain management practice with the largest network of clinics across Georgia (Atlanta, Augusta, Austell, and 20+ additional locations). The practice specializes in non-surgical, minimally invasive treatments for chronic pain conditions affecting the spine, neck, back, joints, and extremities. Clinical offerings include advanced interventional procedures such as spinal cord stimulation, epidural steroid injections, radiofrequency ablation, nerve blocks, medial branch blocks, kyphoplasty, and vertebroplasty. The practice also provides regenerative medicine therapies including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and alpha-2-macroglobulin treatments. Additional services address diabetic neuropathy, sciatica, radiculopathy, spinal stenosis, and osteoporosis-related pain. All providers hold Joint Commission accreditation and work with most major insurance carriers. The multidisciplinary team includes physicians, physician assistants, nurse practitioners, and behavioral health specialists focused on opioid-reduction strategies and root-cause pain management.

Pain Care Labs (dba MMJ Labs) is a leader in noninvasive, drug-free pain relief devices founded in 2006 by Dr. Amy Baxter, a pediatric emergency physician and pain researcher. Headquartered in Atlanta, GA, the company manufactures FDA 510(k)-cleared wearable medical devices utilizing patented mechanical stimulation (M-Stim™) technology, vibration frequencies, and thermal therapies to activate the body's natural pain response system. The company's product portfolio includes Buzzy® (needle pain and fear management for vaccinations, phlebotomy, IV access, and injections, with over 37 million documented procedures); VibraCool® (focal muscle vibration therapy for acute and chronic musculoskeletal pain, post-surgical recovery, and injury management); Buzzy® Pro (adult-focused version for dialysis and blood draw procedures); VibraCool® Pro (intensive M-stim with modular heat and ice for clinical settings); and DuoTherm (patent-pending low back pain brace combining M-stim vibrations with thermal therapy). All devices are rechargeable, reusable, and FDA-cleared. Products are deployed in over 5,000 hospitals and clinics across 28 countries. Pain Care Labs emphasizes cost-effectiveness, clinical evidence (50+ independent studies), patient satisfaction, and opioid-reduction strategies. Distribution includes retail channels (CVS) and direct-to-consumer, healthcare professional, and pharmaceutical partnership models.